Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.CON.RES.42
H.CON.RES.42: Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unu
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced July 21, 2021
- Latest Major Action July 22, 2021
Bill Sponsor
Bill Cosponsors
17 (7 Democrats, 10 Republicans)
Bill Version
- Introduced in House - July 21, 2021
Bill Summary
This concurrent resolution expresses the sense of Congress that government entities should consider using a portion of proceeds from litigation against opioid manufacturers and distributors for drug take-back programs.
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
July 22, 2021 |
Referred to the Subcommittee on Health.
|
July 21, 2021 |
Referred to the House Committee on Energy and Commerce.
|
July 21, 2021 |
Introduced in the House by David McKinley (R-W.Va.) |